Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy

This study has been withdrawn prior to enrollment.

( Study was withdrawn due to lack of enrollment and businesss decisions. )

Study NCT00597909 Information provided by Hyperion Therapeutics, Inc.

First Received: January 9, 2008 Last Updated: April 27, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study was withdrawn before participants were enrolled.

Study Status:	This study has been withdrawn prior to enrollment.
Study Completion Date:	September 2008
Primary Completion Date:	September 2008 (Final data collection date for primary outcome measure)